DrugCite
Search

NUREFLEX

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Nureflex Adverse Events Reported to the FDA Over Time

How are Nureflex adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Nureflex, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Nureflex is flagged as the suspect drug causing the adverse event.

Most Common Nureflex Adverse Events Reported to the FDA

What are the most common Nureflex adverse events reported to the FDA?

Pruritus
7 (4.86%)
Condition Aggravated
4 (2.78%)
Haematoma
4 (2.78%)
Acute Generalised Exanthematous Pus...
3 (2.08%)
Cytolytic Hepatitis
3 (2.08%)
Generalised Erythema
3 (2.08%)
Hepatitis
3 (2.08%)
Pyrexia
3 (2.08%)
Rash Erythematous
3 (2.08%)
Rash Maculo-papular
3 (2.08%)
Renal Failure Acute
3 (2.08%)
Show More Show More
Toxic Skin Eruption
3 (2.08%)
Cheilitis
2 (1.39%)
Convulsion
2 (1.39%)
Eosinophilia
2 (1.39%)
Incorrect Dose Administered
2 (1.39%)
Infection
2 (1.39%)
Leukocytosis
2 (1.39%)
Lung Disorder
2 (1.39%)
Malaise
2 (1.39%)
Neutropenia
2 (1.39%)
Pneumococcal Infection
2 (1.39%)
Pneumonia
2 (1.39%)
Rash Pustular
2 (1.39%)
Abdominal Pain Upper
1 (.69%)
Acute Tonsillitis
1 (.69%)
Alanine Aminotransferase Increased
1 (.69%)
Arthralgia
1 (.69%)
Back Pain
1 (.69%)
Blister
1 (.69%)
Blood Alkaline Phosphatase Increase...
1 (.69%)
Blood Bilirubin Increased
1 (.69%)
Blood Creatinine Increased
1 (.69%)
Bone Pain
1 (.69%)
Brain Oedema
1 (.69%)
Chest Pain
1 (.69%)
Cholestasis
1 (.69%)
Cough
1 (.69%)
Diarrhoea
1 (.69%)
Disorientation
1 (.69%)
Drug Ineffective
1 (.69%)
Drug Interaction
1 (.69%)
Dyspnoea
1 (.69%)
Ecchymosis
1 (.69%)
Effusion
1 (.69%)
Eosinophil Count Increased
1 (.69%)
Epidermal Necrosis
1 (.69%)
Erysipelas
1 (.69%)
Erythema
1 (.69%)
Eyelid Oedema
1 (.69%)
Fall
1 (.69%)
Gamma-glutamyltransferase Increased
1 (.69%)
General Physical Condition Abnormal
1 (.69%)
Hepatic Enzyme Increased
1 (.69%)
Hyperkalaemia
1 (.69%)
Hypersensitivity
1 (.69%)
Hyperthermia
1 (.69%)
Injection Site Haemorrhage
1 (.69%)
International Normalised Ratio Abno...
1 (.69%)
Jaundice
1 (.69%)
Liver Disorder
1 (.69%)
Loss Of Consciousness
1 (.69%)
Lymphadenopathy
1 (.69%)
Lymphocytic Infiltration
1 (.69%)
Mouth Ulceration
1 (.69%)
Multiple Drug Overdose Intentional
1 (.69%)
Myalgia
1 (.69%)
Mydriasis
1 (.69%)
Nausea
1 (.69%)
Neck Pain
1 (.69%)
Nervous System Disorder
1 (.69%)
No Therapeutic Response
1 (.69%)
Odynophagia
1 (.69%)
Overdose
1 (.69%)
Painful Respiration
1 (.69%)
Pemphigoid
1 (.69%)
Pleural Effusion
1 (.69%)
Pleurisy
1 (.69%)
Pneumonia Pneumococcal
1 (.69%)
Prealbumin Decreased
1 (.69%)
Prothrombin Time Ratio Abnormal
1 (.69%)
Pruritus Generalised
1 (.69%)
Psychomotor Retardation
1 (.69%)
Pulmonary Embolism
1 (.69%)
Pupils Unequal
1 (.69%)
Purpura
1 (.69%)
Rash
1 (.69%)
Rectal Haemorrhage
1 (.69%)
Renal Failure
1 (.69%)
Renal Tubular Disorder
1 (.69%)
Respiratory Distress
1 (.69%)
Rhabdomyolysis
1 (.69%)
Skin Exfoliation
1 (.69%)
Somnolence
1 (.69%)
Subdural Haematoma
1 (.69%)
Suicide Attempt
1 (.69%)
Thrombocytopenia
1 (.69%)
Thrombocytopenic Purpura
1 (.69%)
Tubulointerstitial Nephritis
1 (.69%)
Urinary Tract Infection
1 (.69%)
Urticaria
1 (.69%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Nureflex, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Nureflex is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Nureflex

What are the most common Nureflex adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Nureflex, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Nureflex is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Nureflex According to Those Reporting Adverse Events

Why are people taking Nureflex, according to those reporting adverse events to the FDA?

Pain
8
Pyrexia
8
Pain In Extremity
3
Headache
3
Drug Use For Unknown Indication
2
Conjunctivitis
2
Show More Show More
Tonsillitis
2
Acute Tonsillitis
2
Tooth Abscess
1
Haemorrhoids
1
Ear Infection
1
Bronchitis
1
Nasopharyngeal Disorder
1
Nasopharyngitis
1
Ankylosing Spondylitis
1
Arthropathy
1
Osteoarthritis
1
Erysipelas
1
Hygroma Colli
1

Nureflex Case Reports

What Nureflex safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Nureflex. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Nureflex.